Progyny, Inc.
-9.24 %
-23.44 %
Yet to be announced
Company Overview
Progyny is a company that specializes in fertility and family building benefits solutions for employers. The company provides comprehensive fertility benefits solutions, including fertility treatment services, pharmacy benefits management, and ongoing support through patient care advocates. Their services help employees navigate fertility treatments and family building options while managing healthcare costs for employers.
Revenue Sources
PassBased on the company's financial statements and business model, Progyny generates its revenue primarily from fertility benefit solutions and related healthcare services. These core services are halal as they help families with fertility treatments and family building. The company does not derive any significant revenue from prohibited activities.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Dec. 31, 2024 | $298.43m | $282.64m | - | - | 0.00% | 0.00% |
| Sept. 30, 2024 | $286.62m | $274.17m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $304.09m | $283.4m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $278.08m | $258.92m | - | $-630,000.0 | 0.00% | 0.24% |
Looking at the last four quarters of financial data, Progyny shows minimal to no interest income and very low interest expenses. The only notable interest expense was -$632,000 in Q1 2024, which represents an insignificant portion of total expenses. The company's operations are not materially dependent on interest-based income or financing.
Operational Ethics
PassAfter reviewing available public information, SEC filings, and company documentation, there is no evidence of any significant ties or ongoing relationships between Progyny and entities involved in human rights violations such as the state of Israel or the Chinese Communist Party.
Comments